PCPaula Clogher

Paula Clogher

*This is an algorithmically generated author record based on publicly available information.

Paula Clogher has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    841. An Evaluation of Outcomes and Hospital Readmissions Among Individuals with Candidemia in Connecticut (2019-2020)

    by Elizabeth Suschana, David Banach, James Meek, Paula Clogher, Maria Correa

    In addition to significant morbidity and mortality, sepsis is a leading cause of hospital readmission. Candidemia, a leading cause of sepsis, has a particularly high morbidity and mortality rate. Previous studies defined risk factors for poor outcomes and readmission after general sepsis. However, specific risk factors for readmission after candidemia are unknown. The study is retrospective cohort study of adults in Connecticut with an episode of candidemia between 2019-2022 using statewide surveillance data. Individuals were classified based on primary outcome (died versus survived) at incident admission. Candidemia survivors were further classified by readmission status. A descriptive analysis of demographics, healthcare related factors, and readmission characteristics was performed in univariate and multivariate analyses to identify factors associated with mortality and readmission after an episode of candidemia. Demographic and clinical factors of incident case outcome and readmissions, 2019-2020 (Abbreviated). Multivariate analysis for age and class of infection by incident case outcome and readmission status Individuals with candidemia have a high risk of mortality and readmission. Individuals with hospital-onset infection are at particularly high risk of mortality and subsequent readmission. Efforts to prevent hospital-onset candidemia are critical. Additional measures focused on individuals with risk factors for readmission are needed to reduce overall morbidity and mortality associated with candidemia. All Authors: No reported disclosures

  • Changes in the microbiology, epidemiology, and outcomes of candidemia in Connecticut: A comparison between two periods using statewide surveillance

    by Johanna R. Gleason-Vergados, Paula Clogher, James I. Meek, David B. Banach

    Using statewide surveillance, we describe candidemia in Connecticut during 1998–2000 and 2019. In 2019, candidemia was more frequently associated with community-onset and non-albicans Candida species and less frequently associated with central vascular catheters, recent surgery, and in-hospital mortality. Understanding changes in candidemia can optimize clinical management and prevention strategies.

  • Evaluation of Connecticut medical providers’ concordance with 2017 IDSA/SHEA Clostridioides difficile treatment guidelines in New Haven County, 2018–2019

    by Casey Morgan Luc, Danyel Olson, David B. Banach, Paula Clogher, James Hadler

    Objectives: To assess Connecticut medical providers’ concordance (2018–2019) with the 2017 Clostridioides difficile infection (CDI) treatment update by the Infectious Disease Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). The effect of guideline concordance on CDI recurrence risk was also assessed.Design: Prospective, population-based study.Setting: New Haven County, Connecticut, from January 1, 2017, to December 31, 2019.Patients: CDI incident case (no positive tests in the prior 8 weeks), not limited by care setting.Methods: Using data from the Emerging Infections Program’s CDI surveillance, severity and concordance were defined. Presence of megacolon and/or ileus defined fulminant disease; absence defined nonsevere/severe disease. Using 2017 treatment as baseline, 2018–2019 concordance was defined as receiving the recommended first-line antibiotic (ie, vancomycin or fidaxomicin for adult patients, vancomycin or metronidazole for pediatric patients) for exactly 10 days. For all analyses, significance was P < .05.Results: Among 990 cases, concordance increased from 24.8% in 2018 to 37.0% in 2019. First-line antibiotic concordance increased from 61.2% in 2018 to 79.9% in 2019. Recurrence risk was significantly associated with patients aged ≥65 years and was highest for those aged 75–84 years, but this factor was not significantly associated with concordance.Conclusions: From 2018 through 2019, CDI treatment in New Haven County increasingly was concordant with the 2017 treatment update but remained low in 2019. Although concordance with treatment guidelines did not affect recurrence risk, close attention should be paid by medical providers to patients aged ≥65 years, specifically those aged 75–84 years because they are at an increased risk for recurrence.


  • Epidemiology of Antibiotic Use for Urinary Tract Infection in Nursing Home Residents

    by Nicola D. Thompson, Austin Penna, Taniece R. Eure, Wendy M. Bamberg, Grant Barney, Devra Barter, Paula Clogher, Malini B. DeSilva, Ghinwa Dumyati, Erin Epson, et al.


  • Open Access

    Relationship Between Census Tract–Level Poverty and Domestically Acquired Salmonella Incidence: Analysis of Foodborne Diseases Active Surveillance Network Data, 2010–2016

    by James L Hadler, Paula Clogher, Tanya Libby, Elisha Wilson, Nadine Oosmanally, Patricia Ryan, Luke Magnuson, Sarah Lathrop, Suzanne Mcguire, Paul Cieslak, et al.

    Background: The relationships between socioeconomic status and domestically acquired salmonellosis and leading Salmonella serotypes are poorly understood. Methods: We analyzed surveillance data from laboratory-confirmed cases of salmonellosis from 2010–2016 for all 10 Foodborne Disease Active Surveillance Network (FoodNet) sites, having a catchment population of 47.9 million. Case residential data were geocoded, linked to census tract poverty level, and then categorized into 4 groups according to census tract poverty level. After excluding those reporting international travel before illness onset, age-specific and age-adjusted salmonellosis incidence rates were calculated for each census tract poverty level, overall and for each of the 10 leading serotypes. Results: Of 52 821geocodable Salmonella infections (>96%), 48 111 (91.1%) were domestically acquired. Higher age-adjusted incidence occurred with higher census tract poverty level (P < .001; relative risk for highest [≥20%] vs lowest [<5%] census tract poverty level, 1.37). Children <5 years old had the highest relative risk (2.07). Although this relationship was consistent by race/ethnicity and by serotype, it was not present in 5 FoodNet sites or among those aged 18–49 years. Conclusion: Children and older adults living in higher-poverty census tracts have had a higher incidence of domestically acquired salmonellosis. There is a need to understand socioeconomic status differences for risk factors for domestically acquired salmonellosis by age group and FoodNet site to help focus prevention efforts.


  • Open Access

    Multiple‐Aetiology Enteric Infections Involving Non‐O157 Shiga Toxin‐Producing Escherichia coli – FoodNet, 2001–2010

    by R. E. Luna‐Gierke, K. Wymore, J. Sadlowski, P. Clogher, R. W. Gierke, M. Tobin‐D'Angelo, A. Palmer, C. Medus, C. Nicholson, S. McGuire, et al.

    Summary: We describe multiple‐aetiology infections involving non‐O157 Shiga toxin‐producing Escherichia coli (STEC) identified through laboratory‐based surveillance in nine FoodNet sites from 2001 to 2010. A multiple‐aetiology infection (MEI) was defined as isolation of non‐O157 STEC and laboratory evidence of any of the other nine pathogens under surveillance or isolation of >1 non‐O157 STEC serogroup from the same person within a 7‐day period. We compared exposures of patients with MEI during 2001–2010 with those of patients with single‐aetiology non‐O157 STEC infections (SEI) during 2008–2009 and with those of the FoodNet population from a survey conducted during 2006–2007. In total, 1870 non‐O157 STEC infections were reported; 68 (3.6%) were MEI; 60 included pathogens other than non‐O157 STEC; and eight involved >1 serogroup of non‐O157 STEC. Of the 68 MEI, 21 (31%) were part of six outbreaks. STEC O111 was isolated in 44% of all MEI. Of patients with MEI, 50% had contact with farm animals compared with 29% (P < 0.01) of persons with SEI; this difference was driven by infections involving STEC O111. More patients with non‐outbreak‐associated MEI reported drinking well water (62%) than respondents in a population survey (19%) (P < 0.01). Drinking well water and having contact with animals may be important exposures for MEI, especially those involving STEC O111.